U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07545200) titled 'Ultrasonographic Evaluation of Masseter Muscle Changes After Botulinum Toxin Injection in ... Read More
U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07543562) titled 'Selenium Intervention Registry Randomized Trial in Heart Failure' on April 07. Brief Summ... Read More
U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07545720) titled 'Pinoxin for the Prevention of Radiation-Induced Skin Injury' on April 15. Brief Summary: ... Read More
U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07544992) titled 'Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T ... Read More
U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07546110) titled 'An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy o... Read More
U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07544537) titled 'A Prospective Comparative Study of Autologous Bone Marrow-Derived and Adipose Tissue-Deriv... Read More
Singapore, April 23 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 23 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 23 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More
Singapore, April 23 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More